Drug · DIN 02505355
EYLEA
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 17, 2020; first marketed November 17, 2020.
- Drug Identification Number (DIN)
- 02505355
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Aflibercept S01LA05
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFLIBERCEPT | 2 MG | 0.05 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 25, 2020: NOC 24314Supplement to a New Drug Submission (SNDS) · New presentation and new drug product manufacturing site
Other DINs named EYLEA
- DIN 02415992 · Marketed